ArticleDermatology and therapy2023

Topical Sirolimus 0.2% Gel for the Management of Tuberous Sclerosis Complex-Related Cutaneous Manifestations: An Interim Analysis of Postmarketing Surveillance in Japan.

Akemi Egami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.